Our body has an endocannabinoid system (ECS) that regulates various physiological functions, including pain, mood, appetite, and immune response. This system consists of endocannabinoids, enzymes that synthesize and degrade them, and two types of receptors - CB1 and CB2. Interestingly, recent research has found that our skin also has an endocannabinoid system with CB1 and CB2 receptors, which can interact with the cannabinoids found in CBD topicals. These receptors are located in the epidermis, hair follicles, sebaceous glands, and sweat glands. When CBD is applied topically to the skin, it interacts with the CB1 and CB2 receptors, which are responsible for modulating pain and inflammation. By activating these receptors, CBD can help reduce inflammation and provide pain relief. CBD topicals are increasingly being used as a natural alternative to traditional pain management therapies. They are believed to be safe and effective, without the harmful side effects associated with some prescription pain medications. Overall, the discovery of the endocannabinoid system in our skin is an exciting development in the field of natural pain management. It suggests that CBD topicals have the potential to provide targeted relief for localized pain and inflammation.
top of page
bottom of page